Business
Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical
The Saudi Arabia OTC Artificial Tears Market is projected to reach USD 79.09 million by 2033, growing at a CAGR of 4.22% from 2025. Contributing factors include a rising elderly population, increased incidence of dry eye syndrome, and greater use of digital screens. Enhanced awareness of eye health, expanding retail and online pharmacies, and favorable healthcare policies are also promoting market growth. Non-prescription artificial tears offer convenient solutions for mild to moderate condition
About this update from Bausch Health Companies Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The Saudi Arabia OTC Artificial Tears Market is projected to reach USD 79.09 million by 2033, growing at a CAGR of 4.22% from 2025. Contributing factors include a rising elderly population, increased incidence of dry eye syndrome, and greater use of digital screens. Enhanced awareness of eye health, expanding retail and online pharmacies, and favorable healthcare policies are also promoting market growth. Non-prescription artificial tears offer convenient solutions for mild to moderate conditions. Despite regulatory hurdles and high competition, companies like AbbVie, Alcon, and Johnson & Johnson are key players in this growing market.","length":647,"tagName":"p"},{"type":"text","content":"Saudi Arabian OTC Artificial Tears Market","length":41,"tagName":"p"},{"type":"image","alt":"Saudi Arabian OTC Artificial Tears Market","displaySize":"","headline":null,"caption":"Saudi Arabian OTC Artificial Tears Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/7716a2f6563aa30c892a990fd05dabc0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.CC19TcRQlrG2prY0LsfPA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7716a2f6563aa30c892a990fd05dabc0","width":600,"height":400}}},{"type":"text","content":"Dublin, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia OTC Artificial Tears Market - Demand & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering.Saudi Arabia OTC Artificial Tears Market is expected to reach US$ 79.09 million by 2033 from US$ 54.52 million in 2024, with a CAGR of 4.22% from 2025 to 2033.","length":358,"tagName":"p"},{"type":"text","content":"The growing elderly population, rising incidence of dry...